198 related articles for article (PubMed ID: 36264350)
1. Effect of sodium-glucose cotransporter 2 inhibitors on insulin resistance; a systematic review and meta-analysis.
Fakhrolmobasheri M; Abhari AP; Manshaee B; Heidarpour M; Shafie D; Mohammadbeigi E; Mozafari AM; Mazaheri-Tehrani S
Acta Diabetol; 2023 Feb; 60(2):191-202. PubMed ID: 36264350
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis on the efficacy and safety of SGLT2 inhibitors and incretin based agents combination therapy vs. SGLT2i alone or add-on to metformin in type 2 diabetes.
Zhou Y; Geng Z; Wang X; Huang Y; Shen L; Wang Y
Diabetes Metab Res Rev; 2020 Feb; 36(2):e3223. PubMed ID: 31642583
[TBL] [Abstract][Full Text] [Related]
3. Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials.
Li M; Zhang J; Yang G; Zhang J; Han M; Zhang Y; Liu Y
Eur J Clin Pharmacol; 2023 Jun; 79(6):859-871. PubMed ID: 37097298
[TBL] [Abstract][Full Text] [Related]
4. Comparative cardiovascular benefits of individual SGLT2 inhibitors in type 2 diabetes and heart failure: a systematic review and network meta-analysis of randomized controlled trials.
Kongmalai T; Hadnorntun P; Leelahavarong P; Kongmalai P; Srinonprasert V; Chirakarnjanakorn S; Chaikledkaew U; McKay G; Attia J; Thakkinstian A
Front Endocrinol (Lausanne); 2023; 14():1216160. PubMed ID: 38179304
[TBL] [Abstract][Full Text] [Related]
5. Selective sodium-glucose cotransporter-2 inhibitors in the improvement of hemoglobin and hematocrit in patients with type 2 diabetes mellitus: a network meta-analysis.
Luo Y; Bai R; Zhang W; Qin G
Front Endocrinol (Lausanne); 2024; 15():1333624. PubMed ID: 38362282
[TBL] [Abstract][Full Text] [Related]
6. The effect of sodium-glucose cotransporter 2 inhibitors as an adjunct to insulin in patients with type 1 diabetes assessed by continuous glucose monitoring: A systematic review and meta-analysis.
Li M; Liu Z; Yang X; Zhang J; Han M; Zhang Y; Liu Y
J Diabetes Complications; 2023 Dec; 37(12):108632. PubMed ID: 37907042
[TBL] [Abstract][Full Text] [Related]
7. Association between combined treatment with SGLT2 inhibitors and metformin for type 2 diabetes mellitus on fracture risk: a meta-analysis of randomized controlled trials.
Qian BB; Chen Q; Li L; Yan CF
Osteoporos Int; 2020 Dec; 31(12):2313-2320. PubMed ID: 32780153
[TBL] [Abstract][Full Text] [Related]
8. The renoprotective effects of sodium-glucose cotransporter 2 inhibitors versus placebo in patients with type 2 diabetes with or without prevalent kidney disease: A systematic review and meta-analysis.
Wang C; Zhou Y; Kong Z; Wang X; Lv W; Geng Z; Wang Y
Diabetes Obes Metab; 2019 Apr; 21(4):1018-1026. PubMed ID: 30565382
[TBL] [Abstract][Full Text] [Related]
9. Renal, cardiovascular, and safety outcomes of adding sodium-glucose cotransporter-2 inhibitors to insulin therapy in patients with type-2 diabetes: a meta-analysis.
Zhang Q; Zhang Q; Yang L; Yang S; Lu Y
Int Urol Nephrol; 2024 Feb; 56(2):557-570. PubMed ID: 37515749
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials.
Gebrie D; Getnet D; Manyazewal T
Sci Rep; 2021 Jan; 11(1):137. PubMed ID: 33420333
[TBL] [Abstract][Full Text] [Related]
11. Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials.
Scheen AJ
Diabetes Metab; 2020 Jun; 46(3):186-196. PubMed ID: 32007623
[TBL] [Abstract][Full Text] [Related]
12. Impacts of Sodium/Glucose Cotransporter-2 Inhibitors on Circulating Uric Acid Concentrations: A Systematic Review and Meta-Analysis.
Akbari A; Rafiee M; Sathyapalan T; Sahebkar A
J Diabetes Res; 2022; 2022():7520632. PubMed ID: 35224108
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Serum Electrolyte Levels in Patients with Type 2 Diabetes: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials.
Zhang J; Huan Y; Leibensperger M; Seo B; Song Y
Kidney360; 2022 Mar; 3(3):477-487. PubMed ID: 35582188
[TBL] [Abstract][Full Text] [Related]
14. Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials.
Fernandes GC; Fernandes A; Cardoso R; Penalver J; Knijnik L; Mitrani RD; Myerburg RJ; Goldberger JJ
Heart Rhythm; 2021 Jul; 18(7):1098-1105. PubMed ID: 33757845
[TBL] [Abstract][Full Text] [Related]
15. Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
Euh W; Lim S; Kim JW
Front Endocrinol (Lausanne); 2021; 12():613389. PubMed ID: 34177796
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes: A meta-analysis.
Zhuang Y; Song J; Ying M; Li M
Medicine (Baltimore); 2020 Jul; 99(30):e21409. PubMed ID: 32791755
[TBL] [Abstract][Full Text] [Related]
17. Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study.
Li JX; Hung YT; Bair H; Hsu SB; Hsu CY; Lin CJ
Sci Rep; 2023 Oct; 13(1):17049. PubMed ID: 37816862
[TBL] [Abstract][Full Text] [Related]
18. Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus.
Scheen AJ
Nat Rev Endocrinol; 2020 Oct; 16(10):556-577. PubMed ID: 32855502
[TBL] [Abstract][Full Text] [Related]
19. The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials.
Gohari S; Ismail-Beigi F; Mahjani M; Ghobadi S; Jafari A; Ahangar H; Gohari S
BMC Endocr Disord; 2023 Nov; 23(1):257. PubMed ID: 37996879
[TBL] [Abstract][Full Text] [Related]
20. Systematic literature review and network meta-analysis of sodium-glucose co-transporter inhibitors vs metformin as add-on to insulin in type 1 diabetes.
Langford BE; Evans M; Haskins-Coulter T; O'Connor M; Cant HEO; Eddowes LA; Edmonds C; Tank A
Diabetes Obes Metab; 2020 Jan; 22(1):39-50. PubMed ID: 31468649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
